InspireMD, Inc.
NSPR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $3 | $2 | $2 | $2 |
| % Growth | 41.9% | 16.3% | -21.5% | – |
| Cost of Goods Sold | $2 | $1 | $1 | $1 |
| Gross Profit | $1 | $0 | $0 | $0 |
| % Margin | 34.2% | 17.6% | 19.1% | 24.1% |
| R&D Expenses | $4 | $4 | $4 | $4 |
| G&A Expenses | $6 | $5 | $5 | $4 |
| SG&A Expenses | $10 | $9 | $8 | $6 |
| Sales & Mktg Exp. | $4 | $4 | $3 | $2 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $14 | $13 | $12 | $10 |
| Operating Income | -$13 | -$13 | -$11 | -$9 |
| % Margin | -517.3% | -732.2% | -749.5% | -480.6% |
| Other Income/Exp. Net | $0 | -$0 | $0 | $0 |
| Pre-Tax Income | -$13 | -$13 | -$11 | -$9 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$13 | -$13 | -$11 | -$9 |
| % Margin | -503.7% | -739.7% | -730.3% | -470.7% |
| EPS | -0.17 | -0.26 | -0.22 | -0.19 |
| % Growth | 34.6% | -18.2% | -15.8% | – |
| EPS Diluted | -0.17 | -0.26 | -0.22 | -0.19 |
| Weighted Avg Shares Out | 73 | 51 | 50 | 49 |
| Weighted Avg Shares Out Dil | 73 | 51 | 50 | 49 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$13 | -$13 | -$11 | -$9 |
| % Margin | -499.4% | -726.2% | -743.1% | -476.8% |